Utility of health states in chronic kidney disease: a structured review of the literature

被引:30
作者
Dale, P. L. [1 ]
Hutton, J. [1 ]
Elgazzar, H. [2 ]
机构
[1] United BioSource Corp, Hlth Care Analyt Grp, London WC1A 2NS, England
[2] Genzyme, Cambridge, England
关键词
chronic kidney disease; health related quality of life; quality-adjusted life years; quality of life; renal failure; chronic; utility; cost;
D O I
10.1185/030079908X253410
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: To document published utilities for health states associated with Chronic Kidney Disease (CKD) and End Stage Renal Disease (ESRD) and determine the most appropriate values for use in economic models to evaluate renal treatments in the UK. Methods: A structured literature review was conducted (MEDLINE, EMBASE, NHS EED and HTA) in order to identify relevant articles published between January 1990 and January 2006. In addition searches were conducted on websites of Health Technology Assessment (HTA) organizations and the Cost Effectiveness Analysis Registry. Articles were reviewed and those not containing utilities excluded. Results were assessed on the quality of the elicitation studies and their relevance to the UK HTA environment. Results: Thirty-five studies satisfied the inclusion criteria. Most studies were conducted in Canada (13), the US (10) and the Netherlands (4). Utilities were identified for all/most of the necessary states, but scores for individual states differed widely between studies and very few studies met the quality criteria. The majority of studies used the time trade-off (23) and standard gamble (11) to elicit utilities, while only six used EQ-5D. Seven studies provided community preferences. Two studies were judged to be directly relevant to economic evaluations in the UK.6 Conclusions: Many studies have estimated utilities in ESRD patients, but only a few have estimated utilities based upon public preferences. Further empirical research is needed to produce more reliable utilities for economic modelling in the UK, especially in chronic kidney disease patients who do not require dialysis.
引用
收藏
页码:193 / 206
页数:14
相关论文
共 61 条
[1]  
[Anonymous], ARCH HELLENIC MED
[2]  
Arnesen Trude, 2004, J Health Serv Res Policy, V9, P43, DOI 10.1258/135581904322716111
[3]   Cost-effectiveness of interventions for end-stage renal disease [J].
Arredondo, A ;
Rangel, R ;
de Icaza, E .
REVISTA DE SAUDE PUBLICA, 1998, 32 (06) :556-565
[4]   Quality of life in peritoneal dialysis patients: Decline over time and association with clinical outcomes [J].
Bakewell, AB ;
Higgins, RM ;
Edmunds, ME .
KIDNEY INTERNATIONAL, 2002, 61 (01) :239-248
[5]   How strong are patients' preferences in choices between dialysis modalities and doses? [J].
Bass, EB ;
Wills, S ;
Fink, NE ;
Jenckes, MW ;
Sadler, JH ;
Levey, AS ;
Meyer, K ;
Powe, NR .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 44 (04) :695-705
[6]   THE SICKNESS IMPACT PROFILE - DEVELOPMENT AND FINAL REVISION OF A HEALTH-STATUS MEASURE [J].
BERGNER, M ;
BOBBITT, RA ;
CARTER, WB ;
GILSON, BS .
MEDICAL CARE, 1981, 19 (08) :787-805
[7]   The estimation of a preference-based measure of health from the SF-36 [J].
Brazier, J ;
Roberts, J ;
Deverill, M .
JOURNAL OF HEALTH ECONOMICS, 2002, 21 (02) :271-292
[8]   EuroQol: The current state of play [J].
Brooks, R .
HEALTH POLICY, 1996, 37 (01) :53-72
[9]   EFFECT OF HIGH-FLUX HEMODIALYSIS ON QUALITY-OF-LIFE AND NEUROPSYCHOLOGICAL FUNCTION IN CHRONIC-HEMODIALYSIS PATIENTS [J].
CHURCHILL, DN ;
BIRD, DR ;
TAYLOR, DW ;
BEECROFT, ML ;
GORMAN, J ;
WALLACE, JE .
AMERICAN JOURNAL OF NEPHROLOGY, 1992, 12 (06) :412-418
[10]   A COMPARISON OF EVALUATIVE INDEXES OF QUALITY-OF-LIFE AND COGNITIVE FUNCTION IN HEMODIALYSIS-PATIENTS [J].
CHURCHILL, DN ;
WALLACE, JE ;
LUDWIN, D ;
BEECROFT, ML ;
TAYLOR, DW .
CONTROLLED CLINICAL TRIALS, 1991, 12 (04) :S159-S167